Results 221 to 230 of about 52,877 (267)
Some of the next articles are maybe not open access.
Parasitology Today, 1985
Ivermecan was introduced as an antiparasitic agent in 1981. It is now registered for animal-health use in 35 countries and is being evaluated for possible use in man. This review summarises its antiparasitic efficacy and apparent mode of action. Additional information is given in previous review articles.
openaire +2 more sources
Ivermecan was introduced as an antiparasitic agent in 1981. It is now registered for animal-health use in 35 countries and is being evaluated for possible use in man. This review summarises its antiparasitic efficacy and apparent mode of action. Additional information is given in previous review articles.
openaire +2 more sources
Clinical Infectious Diseases, 2021
BACKGROUND Dengue is the most significant mosquito-borne viral disease; there are no specific therapeutics. The antiparasitic drug ivermectin efficiently inhibits the replication of all 4 dengue virus serotypes in vitro.
Y. Suputtamongkol +14 more
semanticscholar +1 more source
BACKGROUND Dengue is the most significant mosquito-borne viral disease; there are no specific therapeutics. The antiparasitic drug ivermectin efficiently inhibits the replication of all 4 dengue virus serotypes in vitro.
Y. Suputtamongkol +14 more
semanticscholar +1 more source
British Journal of Dermatology, 2020
Scabies is a frequent condition seen in infants and children. Only topical treatments have been approved in infants, but some of them are poorly tolerated.
M. Levy +7 more
semanticscholar +1 more source
Scabies is a frequent condition seen in infants and children. Only topical treatments have been approved in infants, but some of them are poorly tolerated.
M. Levy +7 more
semanticscholar +1 more source
Efficacy of Ivermectin Against Onchocerca volvulus in Ghana
Lancet, The, 2007Dirk Engels
exaly +4 more sources

